Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.34.1.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.71 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.71 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.71 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.71 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.33.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.33.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.33.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.33.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.52NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.465ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.465ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.465ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.465NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.2.5 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.2.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.2.5 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.5 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XFORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XFNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
S.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
S.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
S.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
S.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.221.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.221.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.215ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.215ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.215ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.215NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.82ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used